1. OECD: Health Systems Institutional Characteristics. OECD Health Working Papers. 2010, Paris: OECD, 50.
2. Kanavos P: DIFFERENCES IN COSTS OF AND ACCESS TO PHARMACEUTICAL PRODUCTS IN THE EU. Study. 2011, POLICIES DGFI ed. Brussels,: European Parliament
3. Adamski J, Godman B, Ofierska-Sujkowska G, Osinska B, Herholz H, Wendykowska K, Laius O, Jan S, Sermet C, Zara C, et al: Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers. BMC Health Serv Res. 2010, 10: 153-10.1186/1472-6963-10-153.
4. Skjult markedsføringsinitiativ. [
http://taenk.dk/dokumentation/breve/skjult-markedsf%C3%B8ringsinitiativ
]
5. Potenspiller: Fuld tilfredshed eller pengene tilbage. [
http://jp.dk/indland/article237683.ece
]